James Taylor M, Stamou Sotiris C, Faber Cristiano, Nores Marcos A
Graduate Medical Education MD/MPH Program, University of Miami Miller School of Medicine, Miami, Florida.
Department of Cardiothoracic Surgery, JFK Medical Center, Atlantis, Florida.
Int J Angiol. 2019 Dec 31;33(1):29-35. doi: 10.1055/s-0039-3400747. eCollection 2024 Feb.
Few studies have evaluated the outcomes of whole blood microplegia in adult cardiac surgery. Our novel protocol includes removing the crystalloid portion and using the Quest Myocardial Protection System (MPS) for the delivery of del Nido additives in whole blood. This study sought to compare early and late clinical outcomes of whole blood del Nido microplegia (BDN) versus cold blood cardioplegia (CBC) following adult cardiac surgery. A total of 361 patients who underwent cardiac surgery using BDN were compared with a contemporaneous control group of 934 patients receiving CBC. Propensity matching yielded 289 BDN and 289 CBC patients. Chi-square analysis and Fisher's exact test were performed to compare preoperative, operative, and postoperative characteristics on the matched data. Primary outcome was operative mortality, and secondary outcomes included clinical outcomes such as stroke, cardiac arrest, and intra-aortic balloon pump use. The Kaplan-Meier method was used to compare actuarial survival between the two groups using a log-rank test. After matching, preoperative characteristics and surgery type were similar between groups. Cardioplegia type did not affect the primary end point of operative mortality. The rate of postoperative intra-aortic balloon pump was lower in BDN patients compared with CBC patients (0 vs. 2%; = 0.01). There was no difference in late survival. Our novel protocol BDN was comparable with CBC, with similar clinical outcomes and no difference in operative mortality or actuarial survival. Further studies should evaluate the long-term outcomes of this technique.
很少有研究评估成人心脏手术中全血心肌麻痹的效果。我们的新方案包括去除晶体部分,并使用奎斯特心肌保护系统(MPS)在全血中输送德尔尼多添加剂。本研究旨在比较成人心脏手术后全血德尔尼多心肌麻痹(BDN)与冷血心脏停搏液(CBC)的早期和晚期临床效果。
总共361例行BDN心脏手术的患者与同期934例接受CBC的对照组患者进行比较。倾向匹配产生了289例BDN患者和289例CBC患者。进行卡方分析和费舍尔精确检验以比较匹配数据的术前、术中及术后特征。主要结局是手术死亡率,次要结局包括中风、心脏骤停和主动脉内球囊泵使用等临床结局。采用Kaplan-Meier方法,通过对数秩检验比较两组之间的精算生存率。
匹配后,两组间术前特征和手术类型相似。心脏停搏液类型不影响手术死亡率这一主要终点。与CBC患者相比,BDN患者术后主动脉内球囊泵使用率更低(0%对2%;P = 0.01)。晚期生存率无差异。
我们的新方案BDN与CBC相当,临床效果相似,手术死亡率或精算生存率无差异。进一步的研究应评估该技术的长期效果。